Biotech startup Agios Pharmaceuticals has filed to raise $86M in an IPO. The company has raised...

|By:, SA News Editor

Biotech startup Agios Pharmaceuticals has filed to raise $86M in an IPO. The company has raised over a quarter of a billion dollars from VC firms and Celgene (CELG), which has invested $37.5M and made $141.2M in collaboration payments. Celgene has also committed to buying stock in the IPO. Agios has been developing a new approach to treating cancer and metabolic diseases, but has yet to start clinical trials for any of its drug candidates. (S1)